Sales & Marketing Omnichannel didn’t fail biopharma. Our metrics did. Omnichannel didn’t fail pharma. Our metrics did. In 2026, fixing that won’t be optional.
Digital How to build a measurement framework to enable digital produ... Between digital therapeutics, HCP portals, and patient support communications, pharma companies are investing a significant portion of their revenues on digital products.
Patients Eliminating disruption with Eddy Effect metric elevates CX Between ongoing drug shortages, navigating complex insurance benefits, understanding the confusing language of
Views & Analysis How pharma can thrive in the digital era December marks the one year anniversary of the U.S.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.